Pulmonary arteriovenous fistulaArteriovenous malformation - pulmonary
Pulmonary arteriovenous fistula is an abnormal connection between an artery and vein in the lungs. As a result, blood passes through the lungs without receiving enough oxygen.
Pulmonary arteriovenous fistulas are usually the result of abnormal development of the blood vessels of the lung. Most occur in people with hereditary hemorrhagic telangiectasia (HHT). These people often have abnormal blood vessels in many other parts of the body.
Hereditary hemorrhagic telangiectasia (...
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder of the blood vessels that can cause excessive bleeding.
Fistulas also can be a complication of liver disease or lung injury, although these causes are much less common.
Many people have no symptoms. When symptoms occur, they can include:
- Bloody sputum
- Difficulty breathing
- Difficulty exercising
- Shortness of breath with exertion
- Chest pain
- Blue skin (cyanosis)
- Clubbing of the fingers
Exams and Tests
The health care provider will examine you. The exam may show:
- Abnormal blood vessels (telangiectasias) on the skin or mucous membranes
- Abnormal sound, called a murmur when a stethoscope is placed over the abnormal blood vessel
- Low oxygen when measure with a pulse oximeter
Tests that may be done include:
- Arterial blood gas, with and without oxygen (usually oxygen treatment does not improve the arterial blood gas as much as expected)
- Complete blood count (CBC)
- Chest x-ray
- Chest CT scan
- Echocardiogram with bubble study to check the function of the heart and assess for presence of a shunt
- Lung function tests
- Perfusion radionuclide lung scan to measure breathing and circulation (perfusion) in all areas of the lungs
- Pulmonary arteriogram to view the lung arteries
A small number of people who have no symptoms may not need treatment. For most people with fistulas, the treatment of choice is to block the fistula during an arteriogram (embolization).
An arteriogram is an imaging test that uses x-rays and a special dye to see inside the arteries. It can be used to view arteries in the heart, brain...
Some people may need surgery to remove the abnormal vessels and nearby lung tissue.
When arteriovenous fistulas are caused by liver disease, the treatment is a liver transplant.
Liver transplant is surgery to replace a diseased liver with a healthy liver.
The outlook for people with HHT is not as good as for those without HHT. For people without HHT, surgery to remove the abnormal vessels usually has a good outcome, and the condition is not likely to return.
For people with liver disease as a cause, prognosis depends on liver disease.
Complications may include:
- Bleeding in the lung
- Stroke due to blood clot that travels from the lungs to the arms, legs, or brain (paradoxical venous embolism)
- Infection in the brain or heart valve, especially in patients with HHT
When to Contact a Medical Professional
Call your provider if you often have nosebleeds or difficulty breathing, especially if you also have a personal or family history of HHT.
Because HHT is often genetic, prevention is not usually possible. Genetic counseling may help in some cases.
Genetics is the study of heredity, the process of a parent passing certain genes on to their children. A person's appearance, such as height, hair co...
Shovlin CL, Jackson JE. Pulmonary vascular abnormalities. In: Broaddus VC, Mason RJ, Ernst JD, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 6th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 61.
Stowell J, Gilman MD, Walker CM. Congenital thoracic malformations. In: Shepard JO, ed. Thoracic Imaging: The Requisites. 3rd ed. Philadelphia, PA: Elsevier; 2019:chap 8.
Webb GD, Smallhorn JF, Therrien J, Redington AN. Congenital heart disease in the adult and pediatric patient. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 75.
Review Date: 8/3/2020
Reviewed By: Denis Hadjiliadis, MD, MHS, Paul F. Harron Jr. Associate Professor of Medicine, Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.